Article info
PDFSection 6: Education and Research
6ER-012 Efficacy and safety analysis of alemtuzumab in relapsing-remitting multiple sclerosis
Citation
6ER-012 Efficacy and safety analysis of alemtuzumab in relapsing-remitting multiple sclerosis
Publication history
- First published March 11, 2019.
Online issue publication
May 12, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions